UBS upgraded Ingredion from Neutral to Buy and set a new price target of $121.00 from $105.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/7/2025 | $145.00 | Buy → Neutral | UBS |
| 8/9/2024 | $122.00 → $145.00 | Equal Weight → Overweight | Barclays |
| 2/15/2024 | $122.00 → $135.00 | Neutral → Buy | Goldman |
| 9/29/2023 | $120.00 | Outperform | Oppenheimer |
| 4/14/2023 | $115.00 | Market Perform | BMO Capital Markets |
| 4/13/2023 | $105.00 → $121.00 | Neutral → Buy | UBS |
| 1/23/2023 | $105.00 → $110.00 | Overweight → Equal Weight | Barclays |
| 1/17/2023 | $100.00 → $120.00 | Equal-Weight → Overweight | Stephens |